In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
In the latest session, Fortress Biotech Inc (NASDAQ: FBIO) closed at $2.75 down -1.79% from its previous closing price of $2.8. In other words, the price has decreased by -$1.79 from its previous closing price. On the day, 1.0 million shares were traded. FBIO stock price reached its highest trading level at $2.84 during the session, while it also had its lowest trading level at $2.6907.
Ratios:
For a deeper understanding of Fortress Biotech Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.70 and its Current Ratio is at 1.92. In the meantime, Its Debt-to-Equity ratio is 1.58 whereas as Long-Term Debt/Eq ratio is at 1.44.
On August 04, 2022, Ladenburg Thalmann started tracking the stock assigning a Buy rating and target price of $6.
On October 02, 2020, The Benchmark Company started tracking the stock assigning a Buy rating and target price of $9.The Benchmark Company initiated its Buy rating on October 02, 2020, with a $9 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on May 29 ’25 when Fortress Biotech, Inc. sold 100,000 shares for $1.29 per share. The transaction valued at 129,000 led to the insider holds 6,122,249 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, FBIO now has a Market Capitalization of 81825568 and an Enterprise Value of 70120568. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.38 while its Price-to-Book (P/B) ratio in mrq is 1.86. Its current Enterprise Value per Revenue stands at 1.182 whereas that against EBITDA is -0.733.
Stock Price History:
The Beta on a monthly basis for FBIO is 1.65, which has changed by 0.7295598 over the last 52 weeks, in comparison to a change of 0.17904854 over the same period for the S&P500. Over the past 52 weeks, FBIO has reached a high of $4.20, while it has fallen to a 52-week low of $1.33. The 50-Day Moving Average of the stock is 0.22%, while the 200-Day Moving Average is calculated to be 36.10%.
Shares Statistics:
For the past three months, FBIO has traded an average of 892.53K shares per day and 2212550 over the past ten days. A total of 29.75M shares are outstanding, with a floating share count of 23.03M. Insiders hold about 22.61% of the company’s shares, while institutions hold 16.67% stake in the company. Shares short for FBIO as of 1757894400 were 3790877 with a Short Ratio of 4.25, compared to 1755216000 on 2791229. Therefore, it implies a Short% of Shares Outstanding of 3790877 and a Short% of Float of 16.12.
Earnings Estimates
As of right now, 2.0 analysts gave their recommendation on the stock of the company. The consensus estimate for the next quarter is -$0.67, with high estimates of -$0.39 and low estimates of -$0.95.
Analysts are recommending an EPS of between -$0.8 and -$1.79 for the fiscal current year, implying an average EPS of -$1.29. EPS for the following year is -$2.44, with 2.0 analysts recommending between -$1.25 and -$3.64.
Revenue Estimates
A total of 2 analysts believe the company’s revenue will be $21.02M this quarter.It ranges from a high estimate of $23.68M to a low estimate of $18.36M. As of. The current estimate, Fortress Biotech Inc’s year-ago sales were $14.63MFor the next quarter, 2 analysts are estimating revenue of $23.99M. There is a high estimate of $27.49M for the next quarter, whereas the lowest estimate is $20.5M.
A total of 2 analysts have provided revenue estimates for FBIO’s current fiscal year. The highest revenue estimate was $80.7M, while the lowest revenue estimate was $68.41M, resulting in an average revenue estimate of $74.55M. In the same quarter a year ago, actual revenue was $57.67MBased on 2 analysts’ estimates, the company’s revenue will be $107.68M in the next fiscal year. The high estimate is $110.8M and the low estimate is $104.56M.
